Wegovy and Zepbound are part of a wave of obesity medications known as GLP-1 receptor agonists that have soared in popularity ...

Starting on July 1, Wegovy will become the preferred GLP-1 for obesity treatment on CVS Caremark’s largest commercial ...

Trump's Department of Commerce is looking into what it calls national security threats from overseas drug manufacturing, and Lilly CEO David Ricks has personally met with President Donald Trump in ...

Ricks said reshoring manufacturing capacity for older essential medicines is “a valid thing,” adding that Eli Lilly is “happy ...

Currently, 51 countries provide their citizens with some form of universal healthcare while Americans continue to struggle ...

Aetna is once again retreating from the Affordable Care Act market, while its parent company notched a deal with Danish ...

Health officials are poised to announce trials to significantly widen access to the revolutionary injections. They will allow ...

Dr. Google is often on call for worried patients, but it may not give the best advice. Doctors say internet searches for ...

King Charles III described Wednesday how a cancer diagnosis can be a “daunting and at times frightening” experience for ...

Eli Lilly (LLY) reported first quarter earnings on Thursday, beating Wall Street's expectations on the top and bottom lines, ...

AHA comments on the Centers for Medicare & Medicaid Services information collection request regarding the Medicare Transaction Facilitator (MTF) under the Medicare drug negotiation program.

The World Health Organization plans to officially back the use of weight-loss drugs to treat obesity in adults for the first ...